Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
2022 November
  • Home
  • Archive for November, 2022

Don’t start big. Start small and continue small, and it will add up to massive.

  • November 29 2022

Don’t start big. Start small and continue small, and it will add up to massive. How steady improvement can also be a breakthrough

Continue Reading

Human Microbiome Market (4th Edition)

  • November 23 2022

Human Microbiome Market (4th Edition): Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy By L Vijay, November 23, 2022. The human microbiome remained a largely unexplored area until 2007 when the Human Microbiome Project (HMP) was initiated. The project was undertaken to understand the concept of core human microbiome and its compatibility with the host

Continue Reading

The Untapped Potential of Microbiome Mining in Drug Discovery and Precision Medicine

  • November 20 2022

The Untapped Potential of Microbiome Mining in Drug Discovery and Precision Medicine By Ross Youngs, November 17, 2022. Through the innovative practice of microbiome mining, scientists and researchers will be able to harvest and study microbiome molecules at an industrial scale for the first time. Life science is on the verge of ushering in the

Continue Reading
Between Data & Risk
user

Host: Dr. Marian Siwiak linkedin-img

user

Host: Artur Guja linkedin-img


×

Scaling and breakthrough with Ross Young

  • November 20 2022
  • Video - Date: 11/20/2022
  • Length: 24 min

Summary – In this episode, Artur and Marian discuss what is required for scaling technologies and how to achieve breakthroughs. To give a practical example, they interview Ross Youngs, CEO, and founder of Biosortia, who describes his company’s scaling and breakthrough in the field of microbiome harvesting.

Roche Doubles Down on Jnana’s RAPID Platform in $2B Deal

  • November 15 2022

Roche Doubles Down on Jnana’s RAPID Platform in $2B Deal (November 15, 2022) | By Alex Keown. It’s been a lucrative Tuesday for Jnana Therapeutics after it forged a second small molecule discovery and development collaboration and licensing agreement with Roche valued at up to $2 billion. The company also raised $107 million in a

Continue Reading

URI Pharmacy study seeks to identify new toxins in algal blooms

  • November 15 2022

URI Pharmacy study seeks to identify new toxins in algal blooms Assistant Professor Matthew Bertin’s study funded by $400,000 federal grant focuses on freshwater lakes, rivers By Patrick Luce, November 14, 2022. KINGSTON, R.I. — Nov. 14, 2022 — Bacterial algal blooms and the toxins they produce are a persistent problem in freshwater lakes and

Continue Reading

Sanofi taps into Insilico Medicine’s AI platform in deal worth up to $1.2bn

  • November 10 2022

Sanofi taps into Insilico Medicine’s AI platform in deal worth up to $1.2bn (November 10, 2022) | By Rachel Arthur. Sanofi and Insilico Medicine have announced a multi-year, multi-target strategic research collaboration: leveraging Insilico’s ‘Pharma.AI’ platform to advance drug development for up to six new targets.

Continue Reading

Juvena Therapeutics Raises $41M in Series A Funding

  • November 9 2022

Juvena Therapeutics Raises $41M in Series A Funding November 8, 2022 Juvena Therapeutics, a Redwood City, CA-based biotechnology company, raised $41M in Series A funding. The round was led by Mubadala Capital and Horizons Ventures, with participation from Bison Ventures, Manta Ray Ventures, IRONGREY, Alumni Ventures, Plum Alley, Jeff Dean, Transform VC, Karl Pfleger, BoxOne

Continue Reading

I, Microbiome: A Secret to a Healthy and Balanced Human Body

  • November 3 2022

I, Microbiome: A Secret to a Healthy and Balanced Human Body November 03, 2022. Vladimir Jakovljevic. Thank you for including Industrial Scale Microbiome Mining and Biosortia in your new book. Biosortia is excited about the microbiome and the opportunities this virtually unexplored space will deliver to humanity. Therapeutics, agriculture, sustainability, longevity, advanced energy, carbon capture,

Continue Reading
Culture & Innovation
user

Host: Nihad E. K. McBride linkedin-img

user

Guest: Ross Youngs linkedin-img


×

Culture & Innovation: Mining the Human Microbiome

  • November 3 2022
  • Video - Date: 11/03/2022
  • Length: 24:29 min

Summary – Join me and Ross Youngs, a successful innovator, serial entrepreneur, and the founder and CEO of Biosortia, Inc. – Microbiomics, for great insights on how AI and technology support academia, accelerate discovery, and what this means for humanity.

RSS Industry News

  • Examining spatial microbiome variations across gastrointestinal tract regions in obesity July 14 2025
  • Found: a human gut microbe that makes cancer therapy more effective in mice July 14 2025
  • Lactiplantibacillus plantarum dfa1 reduces obesity caused by a high carbohydrate diet by modulating inflammation and gut microbiota July 10 2025
  • Structural and functional characterization of a porcine intestinal microbial ecosystem developed in vitro July 10 2025
  • Gut microbial bile and amino acid metabolism associate with peanut oral immunotherapy failure July 9 2025
  • Quantifying the intra- and inter-species community interactions in microbiomes by dynamic covariance mapping July 9 2025
  • Bacteriome and mycobiome profiling of liquid feed for finisher pigs on commercial pig farms July 9 2025
  • Workouts can help gut microbes to quell cancer July 9 2025
  • Integrated multi-omics of feces, plasma and urine can describe and differentiate pediatric active Crohn’s Disease from remission July 8 2025
  • Gut microbiota composition is related to anxiety and aggression scores in companion dogs July 8 2025
Awesome Image
Biosortia Microbiomics provides small molecules, datasets, & other opportunities from our deep access to the hidden small molecules in microbiomes.
Quick Link
  • Products & Services
  • Blog
  • Contact
Recent Posts
  • Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal
  • UNLOCKING THE TRILLION DOLLAR OPPORTUNITY IN MICROBIOME MINING
  • LEVERAGING ADVANCED TECHNOLOGY
Sign up for our newsletter
Loading
Biosortia Microbiomics © 2024. All Rights Reserved